Course Program

Saturday 24th August

  • Chair | A/Prof David Pattison

    7:50 am | Official Welcome - Prof Jennifer Martin (RACP President), Uncle Billy Cummings (Turrbal People representative) 

    8:10 am | AANMS Theranostics Update - Prof Sze Ting Lee

    8:25 am | How to establish a patient-centred theranostics service - A/Prof Grace Kong

    8:40 am | Radiobiology & theranostics - Dr William Macdonald

    8:55 am | Radiochemistry for the theranostics specialist - Dr Mohammad Haskali

    9:10 am | Medical physics for the theranostics specialist - Dr Kathy Willowson

    9:25 am | Palliative Care Principles for theranostics - Dr Katrina Kramer

    9:40 am | Q&A Panel Discussion

  • Chair | A/Prof Gabby Cehic

    10:30 am | NETs overview & functional syndromes - Dr Cherie Chiang

    10:40 am | NETs surgical treatment principles - A/Prof Benjamin Loveday

    10:50 am | Oncologic treatment of NETs update - Dr David Chan

    11:00 am | Molecular imaging of NETs update - A/Prof Grace Kong

    11:20 am | NET Imaging MDT session - Leads: Nattakorn Dhiantravan & Samuel Kyle | Panel: Grace Kong, Gabby Cehic, David Chan, Cherie Chiang, Benjamin Loveday

    11:50 am | Q&A Panel Discussion

  • Chair | Prof Michael Hofman

    1:10 pm | Peptide Receptor Radionuclide Therapy update - A/Prof Gabby Cehic

    1:30 pm | The NET patient consultation - A/Prof Grace Kong

    1:40 pm | NETs Radionuclide Therapy MDT session - Lead: Grace Kong | Panel: Gabby Cehic, William MacDonald, David Chan, Cherie Chiang, Aaron Wong, Benjamin Loveday

    2:40 pm | Q&A Panel Discussion

  • Chair | Dr William MacDonald

    3:30 pm | Prostate cancer overview & early treatment options - Dr Matthew Roberts

    3:45 pm | Metastatic prostate cancer therapy update - Dr Jeffrey Goh

    4:00 pm | Prostate cancer: a patient perspective - Supported by Movember

    4:10 pm | PSMA PET diagnosis & staging - Prof Michael Hofman

    4:20 pm | PSMA PET in the setting of biochemical recurrence - A/Prof Roslyn Francis

    4:30 pm | PSMA PET response assessment criteria - Prof Louise Emmett

    4:40 pm | Prostate Cancer Imaging MDT session - Leads: Evyn Arnfield & Roslyn Francis | Panel: Oliver Sartor, Michael Hofman, Louise Emmett, Matthew Roberts, Jeffrey Goh

    5:10 pm | Q&A Panel Discussion

Sunday 25th August

  • Chair | Prof Andrew Scott

    8:00 am | Insights from the VISION & PSMAfore trials - Prof Oliver Sartor

    8:10 am | LuPSMA key trials update - Dr Sarennya Pathmanandavel

    8:20 am | Appropriate LuPSMA clinical indications & treatment protocols in 2024 - Prof Michael Hofman

    8:30 am | Patient selection criteria for LuPSMA in 2024 - Dr Nattakorn Dhiantravan

    8:40 am | PSMA Radioligand Therapy MDT session - Leads: Louise Emmett & Sobia Khan | Panel: Oliver Sartor, Michael Hofman, Matthew Roberts, Nattakorn Dhiantravan, Sarrenya Pathmanandavel

    9:40 am | Q&A Panel discussion

  • Chair | A/Prof Roslyn Francis

    10:30 am | Clinical overview & treatment landscape - A/Prof Donald McLeod

    10:50 am | Molecular imaging & RAI therapy overview - Prof Sze Ting Lee

    11:00 am | Re-differentiation therapy & the I-FIRST trial - A/Prof David Pattison

    11:10 am | Advanced thyroid cancer MDT session - Lead: James McNeil | Panel: David Pattison, Elizabeth Thomas, Monica Rossleigh, Donald McLeod, Andrew Scott

    12:10 pm | Q&A Panel Discussion

  • 10:30 am | Welcome to session - Meredith Cummins & Lisa Maddocks

    10:40 am | Carcinoid Heart Disease - Dr Lorcan Ruane

    11:00 am | Carcinoid Syndrome / Crisis Management - Dr Nattakorn Dhiantravan

    11:20 am | Case Study - Stephanie Lindores

    11:45 am | Round table discussion - of other cases - carcinoid crisis

    • other issues

    • networking

    • projects / education

    12:10 pm - Clinical Trials Updates - STOPNET, AusNET, PLANET

    12:30 pm | Session Concludes

  • Chair | Prof Louise Emmett

    1:30 pm | Future of theranostics: alpha & combination therapies - Prof Michael Hofman

    1:45 pm | Paediatric theranostics: neuroblastoma & thyroid cancer update - Dr Elizabeth Thomas

    2:10 pm | Selective Internal Radiation Therapy - Dr Samuel Davis

    2:25 pm | Peptide Receptor Radionuclide Therapy for meningioma- Dr Geoff Schembri

    2:35 pm | Rh-188 for Non Melanoma Skin Cancer - Dr Joe Cardaci

    2:45 pm | Q&A Panel Discussion

  • Chair | Prof Sze Ting Lee

    3:30 pm | Lutetium therapy practicalities: lessons from the coalface - David Macfarlane, Mohammad Haskali, Stephanie Lindores, Matthew Griffiths, Brittany Emerson

    4:10pm | Artificial Intelligence & Theranostics - Dr Aaron Wong

    4:20 pm | Role of ARTNET in Theranostics trials - A/Prof Roslyn Francis

    4:30 pm | Global perspective on theranostics - Prof Andrew Scott

    4:40 pm | Q&A Panel Discussion

    4:55 pm | Concluding remarks A/Prof David Pattison

Program subject to change.